These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16762115)

  • 41. How endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions.
    Lahariya C; Tomar SS
    J Vector Borne Dis; 2011 Mar; 48(1):1-6. PubMed ID: 21406730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A study to compare the effect of adding 12 days DEC regimen to 6 years annual mass drug administration to eliminate microfilaraemia infection in the community in rural Kanpur, Uttar Pradesh, India.
    Kumar A; Sachan P; Bajpei A; Singh T
    J Commun Dis; 2013; 45(1-2):33-40. PubMed ID: 25141552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA).
    Kumar A; Sachan P
    Trop Biomed; 2014 Jun; 31(2):225-9. PubMed ID: 25134891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Awareness of health personnel about lymphatic filariasis and mass drug administration in Kerala State.
    Showkath AM; Regu K; Rajendran R; Mohanan MK; Ganesh B
    J Commun Dis; 2008 Mar; 40(1):37-40. PubMed ID: 19127667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
    Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination.
    Alexander ND
    Trans R Soc Trop Med Hyg; 2015 Mar; 109(3):173-4. PubMed ID: 25575555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
    Bockarie MJ; Deb RM
    Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of education campaign on community-based vector control in hastening the process of elimination of lymphatic filariasis in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K
    Health Educ Res; 2012 Aug; 27(4):585-94. PubMed ID: 21724963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.
    Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA
    Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study on the factors affecting the MDA programme in Kerala state.
    Showkath Ali MK; Rajendran R; Regu K; Mohanan MK; Dhariwal AC; Lal S
    J Commun Dis; 2007 Mar; 39(1):51-6. PubMed ID: 18338717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.
    Njomo DW; Amuyunzu-Nyamongo M; Magambo JK; Njenga SM
    PLoS One; 2012; 7(11):e48395. PubMed ID: 23185256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bridging the gap in outreach and compliance with mass drug administration for lymphatic filariasis elimination in an endemic district in Kerala, India: an intervention research approach.
    Nandha B; Meenakshy V; Abdul Khader N; Vijayakumar KN; Jambulingam P
    Health Educ Res; 2019 Jun; 34(3):300-309. PubMed ID: 30805648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala.
    Aswathy S; Beteena K; Leelamoni K
    Ann Trop Med Parasitol; 2009 Oct; 103(7):617-24. PubMed ID: 19825283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.
    Manyeh AK; Ibisomi L; Ramaswamy R; Baiden F; Chirwa T
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0007009. PubMed ID: 32804967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rapid method to assess the coverage of the mass drug administration of diethylcarbamazine in the program to eliminate lymphatic filariasis in India.
    Babu BV
    Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):44-5. PubMed ID: 15906640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphatic filariasis elimination programme in Andaman and Nicobar Islands, India: drug coverage and compliance post eight rounds of MDA.
    Sunish IP; Shriram AN; Sivan A; Kartick C; Saha BP; Vijayachari P
    Trop Doct; 2013 Jan; 43(1):30-2. PubMed ID: 23550201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes.
    Houston R
    Parasitology; 2000; 121 Suppl():S161-73. PubMed ID: 11386687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
    de Souza DK; Gass K; Otchere J; Htet YM; Asiedu O; Marfo B; Biritwum NK; Boakye DA; Ahorlu CS
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008306. PubMed ID: 32407319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis.
    Krishnamoorthy K; Ramu K; Srividya A; Appavoo NC; Saxena NB; Lal S; Das PK
    Indian J Med Res; 2000 Mar; 111():81-9. PubMed ID: 10937383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are census data accurate for estimating coverage of a lymphatic filariasis MDA campaign? Results of a survey in Sierra Leone.
    Kamara W; Zoerhoff KL; Toubali EH; Hodges MH; Bisanzio D; Chowdhury D; Sonnie M; Magbity E; Samai M; Conteh A; Macarthy F; Baker M; Koroma JB
    PLoS One; 2019; 14(12):e0224422. PubMed ID: 31856176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.